The clinical outcomes of human infections by
With over 500 million clinical cases and 1 million deaths per year, malaria presents a devastating global health problem. Samples from patients with severe disease suggest that binding of malaria-infected red blood cells (iRBCs) to host mammalian cells plays an important role in precipitating blood vessel blockages that can cause organ failure. Yet, some individuals in endemic countries harbor parasites without significant clinical symptoms. To help explore variations in disease outcomes, we developed microfluidic channels that mimic many potential features of severe disease. Synthetic microfluidic channels, with sizes and shapes resembling small capillary networks, were coated with pure host proteins or cultured mammalian cells expressing host ligands. We could therefore simulate binding of iRBCs under high-pressure fluid flow in a realistic capillary environment. By tracking the fate of individual iRBCs, we observed parasite-to-parasite variation in adhesion and an unexpected drop in adhesion when iRBCs passed through the thinnest capillaries. We also showed engulfment of iRBCs by phagocytic cells under fluid flow. The microfluidic devices should serve as powerful field tools for understanding severe malaria because the system is easy to use, requires very small sample volumes, and is portable for on-site analysis of patient samples in the field.
Cellular events that contribute to severe malaria are multi-faceted [
Dissection of the molecular basis for variations in malaria pathogenesis relies on many approaches, each with unique advantages but also significant limitations. For instance, human genetics plays an important role in determining disease severity; human RBC disorders, which cause abnormal expression of surface ligands on iRBCs, can protect patients from disease [
In vitro models for malaria pathogenesis can complement studies of human genetics, autopsies, and animal models. In the past, traditional cell binding assays helped identify relevant host cells [
Microfluidic devices made from elastomeric materials can overcome many of the limitations posed by bulk flow chambers. The fabrication techniques have been specifically developed to engineer devices of diverse shapes with micron-sized dimensions. Thus microfluidics allows for flow experiments in channels that have the same dimensions as capillaries in the microvasculature, using very small sample volumes. We recently showed that a 20-μm microfluidic channel with a 2-μm constriction was able to mimic certain aspects of the physical blockage of a narrow capillary by an infected erythrocyte, even in the absence of any host cells [
To mimic blood flow and cytoadherance of infected erythrocytes in capillaries, microfluidic channels of a variety of shapes and sizes were fabricated, including straight, 50-μm-wide channels, channels with narrow, 4-μm constrictions in them, and bifurcating channels that resembled a network of capillaries. The use of polydimethylsiloxane (PDMS) to create the molds that form the channel walls and ceilings is described in the Methods section and is supported by well established chemistry [
Fluid flow in microfluidic channels with at least one dimension less than 100 μm is well understood. The flow is laminar, has a low Reynolds number, and has a typical parabolic velocity profile, with the maximum velocity at the center of the channel [
To establish our methodology, we used the parasite strain ItG-ICAM-1, which is known to bind intracellular adhesion molecule 1 (ICAM-1), an important ligand mediating cytoadhesion in vivo. Both rolling and stationary adhesion of ItG-ICAM-1 to ICAM-1 under flow conditions have been previously measured at low shear stresses (0.05 Pa and 0.1 Pa) [
Adhesion to ICAM-1 is important for malaria pathogenesis in vivo. ICAM-1 may be particularly important for mediating cytoadhesion in the brain, since immunohistochemical studies have shown that it is upregulated in the cerebral vasculature in fatal malaria cases [
Adhesion of iRBCs to purified ICAM-1 was confirmed in our 50-μm wide × 29-μm tall microfluidic channels even under physiologically relevant shear stresses (applied pressures: 0.5–5 kPa; corresponding shear stress: 0.2–2.5 Pa; [
(A−C) iRBCs rolling on purified protein. RBC solution at 5% hematocrit and 7% parasitemia was flowed at different pressures through a channel functionalized with ICAM-1, as described in the Methods section. At all measured pressures, 86% of cells that adhered to the surface rolled rather than remained stationary. Of cells that rolled, 99% continued rolling for hundreds of microns rather than arresting on the surface or detaching.
(A) Dots mark the spatial position of sample iRBCs every 0.1 s.
(B) Instantaneous velocity of iRBCs.
(C) Distance to origin over 20 s of rolling. At the high pressures shown here (3 kPa), iRBCs on ICAM-1 rolled in a jerky, stepwise fashion with brief, periodic velocity minima occurring approximately every 0.7 s. See also
(D−F) iRBCs rolling on mammalian cells expressing ICAM-1 (CHO-ICAM). CHO-ICAM were seeded in channels as described in the Methods section and grown to confluence under continuous flow conditions for 2 d. RBC suspensions at 5% parasitemia and 10% hematocrit were flowed through the channels at various pressures.
(D) Dots mark the spatial position of a typical iRBC every 0.1 s.
(E) iRBC instantaneous velocity.
(F) Distance to origin of a rolling iRBC at an applied pressure of 2 kPa. On CHO-ICAM, iRBCs move sporadically, often coming to a complete halt before starting to roll again, usually deviating significantly from a straight path. Several iRBCs remain statically adhered and do not roll.
Scale bars = 10 μm. See also
We compared the adhesion of iRBCs under flow conditions to adsorbed ICAM-1 in the presence and absence of soluble ICAM-1. At a pressure of 2 kPa, we found that soluble ICAM-1 inhibited adhesion of ItG-ICAM-1 by up to 85%. Using the microfluidic system, we performed this adhesion inhibition experiment using less than 50 μl of fluid. The use of small volumes of fluid for such experiments will greatly facilitate testing of potential drug or vaccine candidates that block adhesion.
Adhesion was also studied in synthetic microcapillaries seeded with mammalian CHO cells expressing ICAM-1 (CHO-ICAM) and grown to confluence over 2 d. In contrast to behavior on cell-free ICAM-1 ligand, the majority of iRBCs exhibited stationary adhesion on CHO-ICAM (at 0.1 kPa, as well as 3 kPa). Those iRBCs that did roll on CHO-ICAM displayed sporadic behavior, showing large variations in their instantaneous rolling velocities, sometimes coming to a complete halt for several seconds and sometimes detaching from the surface (
The difference in binding to pure ligand versus ligand expressed on mammalian cells was not previously seen in bulk flow chambers that compared rolling of iRBCs on purified ICAM-1 and HUVECs—cells that primarily express ICAM-1 [
Even at high pressures in microchannels, iRBCs carrying the ITG strain of
To illustrate how rolling velocities responded to increasing pressure, we tracked individual iRBCs in a population rolling on either purified CD36 or ICAM-1. On purified CD36, significant rolling required pressures higher than 1 kPa. As pressure increased beyond 1 kPa, iRBCs showed no significant increases in the mean rolling velocities (
Box and whisker plots are generated from tracking the average velocities of populations of
(A) Stabilization of rolling velocities of iRBCs on CD36. At pressures where rolling is observed on CD36, average rolling velocities of most cells remain stable at between approximately 1 and 3 μm/s. Difference between rolling velocities at all pressures was not statistically significant (ANOVA,
(B) Variation in rolling velocity on ICAM-1 at different pressures. Populations of iRBCs on ICAM-1 at different pressures showed inhomogeneity of variances (Levene's test,
The increase in rolling velocities of some cells but not others was not a result of the parabolic fluid velocity profile in a microchannel. First, the measured velocities showed no correlation with the spatial position of iRBCs in the channel; many iRBCs in the same part of the channel had different velocities. Second, all velocity measurements were taken at least 10 μm from the channel walls to exclude any RBCs that may be affected by interactions with the wall. For the aspect ratio used in our devices, the maximum variation in velocity attributable to the parabolic flow profile is approximately 25% [
The plateau in rolling velocities of iRBCs at increasing pressure is qualitatively similar to the stability of leukocyte-rolling velocities on selectins at a wide range of shear stresses, both in vivo and in vitro [
Stabilization of rolling velocities of iRBCs on host ligands could have clinical significance. Regulated rolling on capillaries in vivo may allow iRBCs to evenly sample the endothelium, independent of changing dimensions of the blood vessels and the accompanying changes in wall shear stress. Slightly enhanced stabilization of rolling velocities, even in a subpopulation of infected cells, could thus play an important role in promoting accumulation of iRBCs in capillaries.
Branching capillaries are natural sites in the circulatory system where changes in blood flow patterns can lead to alterations in wall shear stress [
The branching channel was functionalized with ICAM-1.
(A, C) Dots represent the spatial position of two differently behaving, rolling iRBCs every 0.1 s at 3 kPa applied pressure.
(B) Instantaneous velocity of a rolling cell pictured in (A). The iRBC approaches the fork in the channel after approximately 8 s, but shows no change in rolling velocity.
(D) Instantaneous velocity of a rolling iRBC pictured in (C). The iRBC is rolling with a higher velocity than the one pictured in (A) and approaches the fork after approximately 3 s. The iRBC continues rolling in the straight portion of the channel, albeit at a much higher velocity.
Scale bar = 25 μm. See also
In a network of capillaries coated with CD36, a larger number of iRBCs attach in the branches, where shear stress is lower than in the main channel. Applied pressure is 1 kPa across the entire network, making the pressure in individual branches low enough for iRBCs to bind to CD36 in a stationary manner rather than rolling. Image was taken after approximately 10 min of continuous flow.
Scale bar = 50 μm.
Branched channels were also used to determine whether the accumulation of stably adhering iRBCs was dependent on the shear stress in a simulated capillary network. In a channel functionalized with CD36, at pressures where primarily static adhesion is observed, we found increased accumulation of iRBCs in the branches of a model capillary network relative to the main artery (
These studies demonstrate that microfluidic devices can be fabricated to identify and possibly select cell types that will most likely stabilize rolling upon encountering lower shear stresses. They also show how changing shear stresses due to the shape of a capillary in vivo may be critical in determining where cytoadhesion will likely occur. Clearly, sequestration of infected erythrocytes may depend on the
Erythrocytes in the microvasculature can encounter capillaries with dimensions smaller than the RBC diameter. Historically, such constrictions have been thought to interfere with circulation of rigidified iRBCs [
(A) Tracking the movement of an iRBC in a narrowing constriction. Dots mark the spatial position of a typical iRBC every 0.1 s before and after passage through the constriction.
(B) Instantaneous velocity of iRBC. Before reaching the constriction, the iRBC moved with the typical jerky, stepwise motion of rolling iRBCs. The velocity spiked each time an iRBC passed through the constriction.
(C) Distance from origin of an iRBC over time. The iRBC moved uniform distances over each time step before reaching the constriction. The erythrocyte then moved through the entire distance of the constriction within a single time frame of 0.1 s.
Scale bar = 10 μm. See also
The behavior of rolling iRBCs as they approached and passed through 5-μm-wide ligand-coated constrictions dramatically illustrated how microfluidic technology permits experiments that would be impossible in conventional flow chambers. As the rolling iRBCs entered the constriction, they briefly ceased rolling and actually accelerated through the pore. This was recorded as a jump in the distance traveled over the length of the constriction and a corresponding spike in the iRBC velocity (
The rapid traverse of iRBCs in the narrow part of the channel was not due to uneven coating of ICAM-1 on the channel walls; a fluorescently labeled antibody to ICAM confirmed the presence of the ICAM-1 protein throughout the channel, including in the 5-μm constriction. The decreased interaction of iRBCs with adhesive proteins in confined spaces could be due to one of two other reasons. The large pressure drop across the narrow constriction could create wall shear stresses that readily override the adhesion capabilities of iRBCs. Alternatively, the inability of iRBCs to roll in the confined environment could reduce their affinity for adsorbed ligands. Regardless, the presence of the adhesive protein on the surface of the narrow channels did not augment the formation of obstructions within RBC-sized channels. These results suggest that, unless additional events are in play, the narrowest capillaries in vivo may not necessarily be the first to become obstructed with iRBCs.
Clearance of parasites from a naive infected individual is largely dependent on the phagocytosis of iRBCs by macrophages in the spleen. To build on experiments on phagocytosis of iRBCs by macrophages in static cultures [
(A) Differential interference contrast image of RAW macrophages in a 50-μm channel after lysis of attached RBCs. Arrows show the malarial pigment, hemozoin.
(B) Fluorescence image of parasite nuclei ingested by macrophages.
(C) DiIC staining of RBC membranes.
(D) Parasite DNA fluorescence (blue) and RBC membranes (red) merged. Long arrow shows ingestion of entire iRBC, arrowhead shows ingestion of only the parasite, and double arrowhead shows ingestion of RBC without parasite.
Scale bar = 10 μm.
Phagocytosis of infected erythrocytes under shear flow occurred in one of several ways (
Microfluidic devices offer a powerful new opportunity to study malaria pathogenesis and other human diseases that involve the microvasculature. The present laboratory-based applications of this advancing technology illustrate the types of questions in malaria pathogenesis that may be addressed with microfluidics. Since the devices are portable and require mere microliter volumes of samples, future applications should be possible at field sites, using matched patient samples. Such studies could include parasitized blood, serum, platelets, antibodies, phagocytic cells, and possibly biopsied host samples. We expect that the most valuable insights into the causes of severe malaria will arise from detailed studies of variations in human and parasite samples at field sites.
Technically, even though the fabrication of the silicon master for a specific experimental application requires an experienced materials science engineer and a specialized clean room facility, subsequent production of dozens of PDMS devices from a common master is inexpensive and easy to learn. As illustrated, the soft lithography methodology allows for the design of channels of a wide variety of shapes and very small sizes, and the gas-permeable PDMS polymer readily accommodates long-term cell growth of multiple cell types in channels. The microfluidic devices can be mounted on a microscope, and data on single cells can be collected as still photos or as movies on a personal computer for further detailed analysis. In addition to their use in field sites, we expect the devices to be popular in standard research laboratories where access to traditional flow adhesion apparatus is either unavailable or impractical due to the large volumes of sample needed.
Microfluidic silicon masters were fabricated using standard photolithographic techniques [
The ICAM-1–adherent laboratory line of
CHO cells transfected with CD36 were a gift from Joseph Smith, and CHO cells transfected with ICAM-1 were obtained from ATCC (
The channels were first rinsed continuously with a flow of ethanol for about 10 min, followed by rinsing with a 4% solution of aminopropylethoxysilane (APES; Sigma-Aldrich,
For adhesion blocking with soluble ICAM-1, 3 μl of packed RBCs enriched to 30% parasitemia using Plasmion plasmagel were incubated in 50 μl of ICAM-1 at a concentration of 50 μg/ml for 15 min at 37 °C. The RBC solution was then flowed through the microfluidic chamber at a pressure of 2 kPa for 12 min, after which the number of attached cells were counted over at least eight different fields of view. The number of attached cells was compared with the number obtained by flowing into the channel an equivalent concentration of iRBCs that were not exposed to soluble ICAM-1 at the same pressure for the same time.
Channels were first incubated with the appropriate cell culture media for approximately 1 h at 37 °C prior to introducing cells. About 200 μl of cells in media were pipetted into the channel reservoir at a concentration of about 5 million cells/ml. The cells were pulled into the channel and allowed to settle. Unattached cells were rinsed away and the process was repeated to achieve an attached cell density that would support the growth of a confluent monolayer. Cells in the channels were grown under continuous fluid flow for up to 3 d and shown to be alive using a fluorescent Live/Dead Cell Vitality Assay (Molecular Probes,
All imaging of cells and channels was carried out on an inverted fluorescence microscope (Nikon TE200 or TE2000;
Movies of rolling iRBCs were analyzed using the tracking software on the Metamorph Imaging System.
RAW macrophages were seeded and grown in 50 μm × 29 μm channels and iRBC cultures introduced at a pressure of 0.1 kPa. Channels were kept overnight in an incubator at 37 °C and 5% CO2, with the flow rate maintained by gravity. Infected erythrocytes were counted by taking an average of approximately 20 random fields of view of the attached macrophages in the channel. Phagocytosis was measured after lysis of attached erythrocytes with cold water, as previously described [
(2.4 MB MPG)
Click here for additional data file.
(2.9 MB MPG)
Click here for additional data file.
(622 KB MPG)
Click here for additional data file.
(491 KB MPG)
Click here for additional data file.
The authors thank J. Smith (SBRI, Seattle, Washington, United States) for key cell lines, D. Chiu and J. Kuo (University of Washington, Seattle, Washington, United States) for guidance and access to their plasma sealer, the Washington Technology Center (Seattle, Washington, United States) for access to silicon master fabrication facilities, and the University of Washington Engineered Biomaterials (UWEB) Optical Microscopy and Image Analysis Shared Resource (Seattle, Washington, United States).
mammalian CHO cells expressing ICAM-1
intracellular adhesion molecule 1
infected red blood cell
polydimethylsiloxane
red blood cell